• +91 9169164321 (Asia)
  • +1(646)-781-7170 (Int'l)
  • help@24lifesciences.com
Cart (0)

Global and United States Medical Hemostatic Agents Market Insights, Forecast to 2026

report cover
  • 3 September 2020
  • Healthcare
  • 146 Pages
  • Report Code: 24LS-21450
  • Formate :   
Download FREE Report Sample Download PDF File

United States Medical Hemostatic Agents -MARKET ADVISORY SERVICES

Medical Hemostatic Agents market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Medical Hemostatic Agents market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Medical Hemostatic Agents market is segmented into
Gelation Sponge
Oxidized Regenerated Cellulose Based Hemostats
Others

Segment by Application, the Medical Hemostatic Agents market is segmented into
Hospitals
Surgical Centers
Clnics
Others

Regional and Country-level Analysis
The Medical Hemostatic Agents market is analysed and market size information is provided by regions (countries).
The key regions covered in the Medical Hemostatic Agents market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Medical Hemostatic Agents Market Share Analysis
Medical Hemostatic Agents market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Medical Hemostatic Agents business, the date to enter into the Medical Hemostatic Agents market, Medical Hemostatic Agents product introduction, recent developments, etc.
The major vendors covered:
Ethicon
Pfizer
Baxter International
C. R. Bard
The Medicines Company
Anika Therapeutics
Advanced Medical Solutions
Integra LifeSciences
B Braun Melsungen
Gelita Medical
Equimedical
Vascular Solutions
Marine Polymer Technologies
Z-Medica
CryoLife
BioCer Entwicklungs
Biom’Up SAS
1 Study Coverage
1.1 Medical Hemostatic Agents Product Introduction
1.2 Market Segments
1.3 Key Medical Hemostatic Agents Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Medical Hemostatic Agents Market Size Growth Rate by Type
1.4.2 Gelation Sponge
1.4.3 Oxidized Regenerated Cellulose Based Hemostats
1.4.4 Others
1.5 Market by Application
1.5.1 Global Medical Hemostatic Agents Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Surgical Centers
1.5.4 Clnics
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Medical Hemostatic Agents Market Size, Estimates and Forecasts
2.1.1 Global Medical Hemostatic Agents Revenue 2015-2026
2.1.2 Global Medical Hemostatic Agents Sales 2015-2026
2.2 Global Medical Hemostatic Agents, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Medical Hemostatic Agents Historical Market Size by Region (2015-2020)
2.3.1 Global Medical Hemostatic Agents Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Medical Hemostatic Agents Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Medical Hemostatic Agents Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Medical Hemostatic Agents Sales Forecast by Region (2021-2026)
2.4.2 Global Medical Hemostatic Agents Revenue Forecast by Region (2021-2026)

3 Global Medical Hemostatic Agents Competitor Landscape by Players
3.1 Global Top Medical Hemostatic Agents Sales by Manufacturers
3.1.1 Global Medical Hemostatic Agents Sales by Manufacturers (2015-2020)
3.1.2 Global Medical Hemostatic Agents Sales Market Share by Manufacturers (2015-2020)
3.2 Global Medical Hemostatic Agents Manufacturers by Revenue
3.2.1 Global Medical Hemostatic Agents Revenue by Manufacturers (2015-2020)
3.2.2 Global Medical Hemostatic Agents Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Medical Hemostatic Agents Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Medical Hemostatic Agents Revenue in 2019
3.2.5 Global Medical Hemostatic Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Medical Hemostatic Agents Price by Manufacturers
3.4 Global Medical Hemostatic Agents Manufacturing Base Distribution, Product Types
3.4.1 Medical Hemostatic Agents Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Medical Hemostatic Agents Product Type
3.4.3 Date of International Manufacturers Enter into Medical Hemostatic Agents Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Medical Hemostatic Agents Market Size by Type (2015-2020)
4.1.1 Global Medical Hemostatic Agents Sales by Type (2015-2020)
4.1.2 Global Medical Hemostatic Agents Revenue by Type (2015-2020)
4.1.3 Medical Hemostatic Agents Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Medical Hemostatic Agents Market Size Forecast by Type (2021-2026)
4.2.1 Global Medical Hemostatic Agents Sales Forecast by Type (2021-2026)
4.2.2 Global Medical Hemostatic Agents Revenue Forecast by Type (2021-2026)
4.2.3 Medical Hemostatic Agents Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Medical Hemostatic Agents Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Medical Hemostatic Agents Market Size by Application (2015-2020)
5.1.1 Global Medical Hemostatic Agents Sales by Application (2015-2020)
5.1.2 Global Medical Hemostatic Agents Revenue by Application (2015-2020)
5.1.3 Medical Hemostatic Agents Price by Application (2015-2020)
5.2 Medical Hemostatic Agents Market Size Forecast by Application (2021-2026)
5.2.1 Global Medical Hemostatic Agents Sales Forecast by Application (2021-2026)
5.2.2 Global Medical Hemostatic Agents Revenue Forecast by Application (2021-2026)
5.2.3 Global Medical Hemostatic Agents Price Forecast by Application (2021-2026)

6 United States by Players, Type and Application
6.1 United States Medical Hemostatic Agents Market Size YoY Growth 2015-2026
6.1.1 United States Medical Hemostatic Agents Sales YoY Growth 2015-2026
6.1.2 United States Medical Hemostatic Agents Revenue YoY Growth 2015-2026
6.1.3 United States Medical Hemostatic Agents Market Share in Global Market 2015-2026
6.2 United States Medical Hemostatic Agents Market Size by Players (International and Local Players)
6.2.1 United States Top Medical Hemostatic Agents Players by Sales (2015-2020)
6.2.2 United States Top Medical Hemostatic Agents Players by Revenue (2015-2020)
6.3 United States Medical Hemostatic Agents Historic Market Review by Type (2015-2020)
6.3.1 United States Medical Hemostatic Agents Sales Market Share by Type (2015-2020)
6.3.2 United States Medical Hemostatic Agents Revenue Market Share by Type (2015-2020)
6.3.3 United States Medical Hemostatic Agents Price by Type (2015-2020)
6.4 United States Medical Hemostatic Agents Market Estimates and Forecasts by Type (2021-2026)
6.4.1 United States Medical Hemostatic Agents Sales Forecast by Type (2021-2026)
6.4.2 United States Medical Hemostatic Agents Revenue Forecast by Type (2021-2026)
6.4.3 United States Medical Hemostatic Agents Price Forecast by Type (2021-2026)
6.5 United States Medical Hemostatic Agents Historic Market Review by Application (2015-2020)
6.5.1 United States Medical Hemostatic Agents Sales Market Share by Application (2015-2020)
6.5.2 United States Medical Hemostatic Agents Revenue Market Share by Application (2015-2020)
6.5.3 United States Medical Hemostatic Agents Price by Application (2015-2020)
6.6 United States Medical Hemostatic Agents Market Estimates and Forecasts by Application (2021-2026)
6.6.1 United States Medical Hemostatic Agents Sales Forecast by Application (2021-2026)
6.6.2 United States Medical Hemostatic Agents Revenue Forecast by Application (2021-2026)
6.6.3 United States Medical Hemostatic Agents Price Forecast by Application (2021-2026)

7 North America
7.1 North America Medical Hemostatic Agents Market Size YoY Growth 2015-2026
7.2 North America Medical Hemostatic Agents Market Facts & Figures by Country
7.2.1 North America Medical Hemostatic Agents Sales by Country (2015-2020)
7.2.2 North America Medical Hemostatic Agents Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada

8 Europe
8.1 Europe Medical Hemostatic Agents Market Size YoY Growth 2015-2026
8.2 Europe Medical Hemostatic Agents Market Facts & Figures by Country
8.2.1 Europe Medical Hemostatic Agents Sales by Country
8.2.2 Europe Medical Hemostatic Agents Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia

9 Asia Pacific
9.1 Asia Pacific Medical Hemostatic Agents Market Size YoY Growth 2015-2026
9.2 Asia Pacific Medical Hemostatic Agents Market Facts & Figures by Country
9.2.1 Asia Pacific Medical Hemostatic Agents Sales by Region (2015-2020)
9.2.2 Asia Pacific Medical Hemostatic Agents Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam

10 Latin America
10.1 Latin America Medical Hemostatic Agents Market Size YoY Growth 2015-2026
10.2 Latin America Medical Hemostatic Agents Market Facts & Figures by Country
10.2.1 Latin America Medical Hemostatic Agents Sales by Country
10.2.2 Latin America Medical Hemostatic Agents Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Medical Hemostatic Agents Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Medical Hemostatic Agents Market Facts & Figures by Country
11.2.1 Middle East and Africa Medical Hemostatic Agents Sales by Country
11.2.2 Middle East and Africa Medical Hemostatic Agents Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E

12 Company Profiles
12.1 Ethicon
12.1.1 Ethicon Corporation Information
12.1.2 Ethicon Description and Business Overview
12.1.3 Ethicon Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Ethicon Medical Hemostatic Agents Products Offered
12.1.5 Ethicon Recent Development
12.2 Pfizer
12.2.1 Pfizer Corporation Information
12.2.2 Pfizer Description and Business Overview
12.2.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Pfizer Medical Hemostatic Agents Products Offered
12.2.5 Pfizer Recent Development
12.3 Baxter International
12.3.1 Baxter International Corporation Information
12.3.2 Baxter International Description and Business Overview
12.3.3 Baxter International Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Baxter International Medical Hemostatic Agents Products Offered
12.3.5 Baxter International Recent Development
12.4 C. R. Bard
12.4.1 C. R. Bard Corporation Information
12.4.2 C. R. Bard Description and Business Overview
12.4.3 C. R. Bard Sales, Revenue and Gross Margin (2015-2020)
12.4.4 C. R. Bard Medical Hemostatic Agents Products Offered
12.4.5 C. R. Bard Recent Development
12.5 The Medicines Company
12.5.1 The Medicines Company Corporation Information
12.5.2 The Medicines Company Description and Business Overview
12.5.3 The Medicines Company Sales, Revenue and Gross Margin (2015-2020)
12.5.4 The Medicines Company Medical Hemostatic Agents Products Offered
12.5.5 The Medicines Company Recent Development
12.6 Anika Therapeutics
12.6.1 Anika Therapeutics Corporation Information
12.6.2 Anika Therapeutics Description and Business Overview
12.6.3 Anika Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Anika Therapeutics Medical Hemostatic Agents Products Offered
12.6.5 Anika Therapeutics Recent Development
12.7 Advanced Medical Solutions
12.7.1 Advanced Medical Solutions Corporation Information
12.7.2 Advanced Medical Solutions Description and Business Overview
12.7.3 Advanced Medical Solutions Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Advanced Medical Solutions Medical Hemostatic Agents Products Offered
12.7.5 Advanced Medical Solutions Recent Development
12.8 Integra LifeSciences
12.8.1 Integra LifeSciences Corporation Information
12.8.2 Integra LifeSciences Description and Business Overview
12.8.3 Integra LifeSciences Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Integra LifeSciences Medical Hemostatic Agents Products Offered
12.8.5 Integra LifeSciences Recent Development
12.9 B Braun Melsungen
12.9.1 B Braun Melsungen Corporation Information
12.9.2 B Braun Melsungen Description and Business Overview
12.9.3 B Braun Melsungen Sales, Revenue and Gross Margin (2015-2020)
12.9.4 B Braun Melsungen Medical Hemostatic Agents Products Offered
12.9.5 B Braun Melsungen Recent Development
12.10 Gelita Medical
12.10.1 Gelita Medical Corporation Information
12.10.2 Gelita Medical Description and Business Overview
12.10.3 Gelita Medical Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Gelita Medical Medical Hemostatic Agents Products Offered
12.10.5 Gelita Medical Recent Development
12.11 Ethicon
12.11.1 Ethicon Corporation Information
12.11.2 Ethicon Description and Business Overview
12.11.3 Ethicon Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Ethicon Medical Hemostatic Agents Products Offered
12.11.5 Ethicon Recent Development
12.12 Vascular Solutions
12.12.1 Vascular Solutions Corporation Information
12.12.2 Vascular Solutions Description and Business Overview
12.12.3 Vascular Solutions Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Vascular Solutions Products Offered
12.12.5 Vascular Solutions Recent Development
12.13 Marine Polymer Technologies
12.13.1 Marine Polymer Technologies Corporation Information
12.13.2 Marine Polymer Technologies Description and Business Overview
12.13.3 Marine Polymer Technologies Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Marine Polymer Technologies Products Offered
12.13.5 Marine Polymer Technologies Recent Development
12.14 Z-Medica
12.14.1 Z-Medica Corporation Information
12.14.2 Z-Medica Description and Business Overview
12.14.3 Z-Medica Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Z-Medica Products Offered
12.14.5 Z-Medica Recent Development
12.15 CryoLife
12.15.1 CryoLife Corporation Information
12.15.2 CryoLife Description and Business Overview
12.15.3 CryoLife Sales, Revenue and Gross Margin (2015-2020)
12.15.4 CryoLife Products Offered
12.15.5 CryoLife Recent Development
12.16 BioCer Entwicklungs
12.16.1 BioCer Entwicklungs Corporation Information
12.16.2 BioCer Entwicklungs Description and Business Overview
12.16.3 BioCer Entwicklungs Sales, Revenue and Gross Margin (2015-2020)
12.16.4 BioCer Entwicklungs Products Offered
12.16.5 BioCer Entwicklungs Recent Development
12.17 Biom’Up SAS
12.17.1 Biom’Up SAS Corporation Information
12.17.2 Biom’Up SAS Description and Business Overview
12.17.3 Biom’Up SAS Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Biom’Up SAS Products Offered
12.17.5 Biom’Up SAS Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Medical Hemostatic Agents Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Medical Hemostatic Agents Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables

Table 1. Medical Hemostatic Agents Market Segments

Table 2. Ranking of Global Top Medical Hemostatic Agents Manufacturers by Revenue (US$ Million) in 2019

Table 3. Global Medical Hemostatic Agents Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)

Table 4. Major Manufacturers of Gelation Sponge

Table 5. Major Manufacturers of Oxidized Regenerated Cellulose Based Hemostats

Table 6. Major Manufacturers of Others

Table 7. Global Medical Hemostatic Agents Market Size Growth Rate by Application 2020-2026 (K Units)

Table 8. Global Medical Hemostatic Agents Market Size by Region (K Units) & (US$ Million): 2020 VS 2026

Table 9. Global Medical Hemostatic Agents Sales by Regions 2015-2020 (K Units)

Table 10. Global Medical Hemostatic Agents Sales Market Share by Regions (2015-2020)

Table 11. Global Medical Hemostatic Agents Revenue by Regions 2015-2020 (US$ Million)

Table 12. Global Medical Hemostatic Agents Sales Forecast by Region (2021-2026) (K Units)

Table 13. Global Medical Hemostatic Agents Sales by Manufacturers (2015-2020) (K Units)

Table 14. Global Medical Hemostatic Agents Sales Share by Manufacturers (2015-2020)

Table 15. Global Medical Hemostatic Agents Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)

Table 16. Global Medical Hemostatic Agents by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Medical Hemostatic Agents as of 2019)

Table 17. Medical Hemostatic Agents Revenue by Manufacturers (2015-2020) (US$ Million)

Table 18. Medical Hemostatic Agents Revenue Share by Manufacturers (2015-2020)

Table 19. Key Manufacturers Medical Hemostatic Agents Price (2015-2020) (USD/Unit)

Table 20. Medical Hemostatic Agents Manufacturers Manufacturing Base Distribution and Headquarters

Table 21. Manufacturers Medical Hemostatic Agents Product Type

Table 22. Date of International Manufacturers Enter into Medical Hemostatic Agents Market

Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 24. Global Medical Hemostatic Agents Sales by Type (2015-2020) (K Units)

Table 25. Global Medical Hemostatic Agents Sales Share by Type (2015-2020)

Table 26. Global Medical Hemostatic Agents Revenue by Type (2015-2020) (US$ Million)

Table 27. Global Medical Hemostatic Agents Revenue Share by Type (2015-2020)

Table 28. Medical Hemostatic Agents Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)

Table 29. Global Medical Hemostatic Agents Sales Share by Type (2021-2026)

Table 30. Global Medical Hemostatic Agents Sales by Application (2015-2020) (K Units)

Table 31. Global Medical Hemostatic Agents Sales Share by Application (2015-2020)

Table 32. Global Medical Hemostatic Agents Sales Share by Application (2021-2026)

Table 33. Global Medical Hemostatic Agents Sales Market Share Forecast by Application (2021-2026)

Table 34. Global Medical Hemostatic Agents Revenue by Application (2015-2020) (US$ Million)

Table 35. Global Medical Hemostatic Agents Revenue Market Share Forecast by Application (2021-2026)

Table 36. United States Medical Hemostatic Agents Sales (K Units) of Key Companies (2015-2020)

Table 37. United States Medical Hemostatic Agents Sales Share by Company (2015-2020)

Table 38. United States Medical Hemostatic Agents Revenue (US$ Million) by Company (2015-2020)

Table 39. United States Medical Hemostatic Agents Sales (K Units) by Type (2015-2020)

Table 40. United States Medical Hemostatic Agents Sales Share by Type (2015-2020)

Table 41. United States Medical Hemostatic Agents Revenue (US$ Million) Market Share by Type (2015-2020)

Table 42. United States Medical Hemostatic Agents Price (K Units) by Type (2015-2020)

Table 43. United States Medical Hemostatic Agents Sales (K Units) by Type (2021-2026)

Table 44. United States Medical Hemostatic Agents Sales Share by Type (2021-2026)

Table 45. United States Medical Hemostatic Agents Revenue (US$ Million) Market Share by Type (2021-2026)

Table 46. United States Medical Hemostatic Agents Revenue Share by Type (2021-2026)

Table 47. United States Medical Hemostatic Agents Price (K Units) by Type (2021-2026)

Table 48. United States Medical Hemostatic Agents Sales (K Units) by Application (2015-2020)

Table 49. United States Medical Hemostatic Agents Sales Share by Application (2015-2020)

Table 50. United States Medical Hemostatic Agents Revenue (US$ Million) Market Share by Application (2015-2020)

Table 51. United States Medical Hemostatic Agents Sales (K Units) by Application (2021-2026)

Table 52. United States Medical Hemostatic Agents Sales Share by Application (2021-2026)

Table 53. United States Medical Hemostatic Agents Revenue (US$ Million) Market Share by Application (2021-2026)

Table 54. United States Medical Hemostatic Agents Revenue Share by Application (2021-2026)

Table 55. North America Medical Hemostatic Agents Sales by Country (2015-2020) (K Units)

Table 56. North America Medical Hemostatic Agents Sales Market Share by Country (2015-2020)

Table 57. North America Medical Hemostatic Agents Revenue by Country (2015-2020) (US$ Million)

Table 58. North America Medical Hemostatic Agents Revenue Market Share by Country (2015-2020)

Table 59. Europe Medical Hemostatic Agents Sales by Country (2015-2020) (K Units)

Table 60. Europe Medical Hemostatic Agents Sales Market Share by Country (2015-2020)

Table 61. Europe Medical Hemostatic Agents Revenue by Country (2015-2020) (US$ Million)

Table 62. Europe Medical Hemostatic Agents Revenue Market Share by Country (2015-2020)

Table 63. Asia Pacific Medical Hemostatic Agents Sales by Region (2015-2020) (K Units)

Table 64. Asia Pacific Medical Hemostatic Agents Sales Market Share by Region (2015-2020)

Table 65. Asia Pacific Medical Hemostatic Agents Revenue by Region (2015-2020) (US$ Million)

Table 66. Asia Pacific Medical Hemostatic Agents Revenue Market Share by Region (2015-2020)

Table 67. Latin America Medical Hemostatic Agents Sales by Country (2015-2020) (K Units)

Table 68. Latin America Medical Hemostatic Agents Sales Market Share by Country (2015-2020)

Table 69. Latin Americaa Medical Hemostatic Agents Revenue by Country (2015-2020) (US$ Million)

Table 70. Latin America Medical Hemostatic Agents Revenue Market Share by Country (2015-2020)

Table 71. Middle East and Africa Medical Hemostatic Agents Sales by Country (2015-2020) (K Units)

Table 72. Middle East and Africa Medical Hemostatic Agents Sales Market Share by Country (2015-2020)

Table 73. Middle East and Africa Medical Hemostatic Agents Revenue by Country (2015-2020) (US$ Million)

Table 74. Middle East and Africa Medical Hemostatic Agents Revenue Market Share by Country (2015-2020)

Table 75. Ethicon Corporation Information

Table 76. Ethicon Description and Business Overview

Table 77. Ethicon Medical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 78. Ethicon Medical Hemostatic Agents Product

Table 79. Ethicon Recent Development

Table 80. Pfizer Corporation Information

Table 81. Pfizer Description and Business Overview

Table 82. Pfizer Medical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 83. Pfizer Product

Table 84. Pfizer Recent Development

Table 85. Baxter International Corporation Information

Table 86. Baxter International Description and Business Overview

Table 87. Baxter International Medical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 88. Baxter International Product

Table 89. Baxter International Recent Development

Table 90. C. R. Bard Corporation Information

Table 91. C. R. Bard Description and Business Overview

Table 92. C. R. Bard Medical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 93. C. R. Bard Product

Table 94. C. R. Bard Recent Development

Table 95. The Medicines Company Corporation Information

Table 96. The Medicines Company Description and Business Overview

Table 97. The Medicines Company Medical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 98. The Medicines Company Product

Table 99. The Medicines Company Recent Development

Table 100. Anika Therapeutics Corporation Information

Table 101. Anika Therapeutics Description and Business Overview

Table 102. Anika Therapeutics Medical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 103. Anika Therapeutics Product

Table 104. Anika Therapeutics Recent Development

Table 105. Advanced Medical Solutions Corporation Information

Table 106. Advanced Medical Solutions Description and Business Overview

Table 107. Advanced Medical Solutions Medical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 108. Advanced Medical Solutions Product

Table 109. Advanced Medical Solutions Recent Development

Table 110. Integra LifeSciences Corporation Information

Table 111. Integra LifeSciences Description and Business Overview

Table 112. Integra LifeSciences Medical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 113. Integra LifeSciences Product

Table 114. Integra LifeSciences Recent Development

Table 115. B Braun Melsungen Corporation Information

Table 116. B Braun Melsungen Description and Business Overview

Table 117. B Braun Melsungen Medical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 118. B Braun Melsungen Product

Table 119. B Braun Melsungen Recent Development

Table 120. Gelita Medical Corporation Information

Table 121. Gelita Medical Description and Business Overview

Table 122. Gelita Medical Medical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 123. Gelita Medical Product

Table 124. Gelita Medical Recent Development

Table 125. Equimedical Corporation Information

Table 126. Equimedical Description and Business Overview

Table 127. Equimedical Medical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 128. Equimedical Product

Table 129. Equimedical Recent Development

Table 130. Vascular Solutions Corporation Information

Table 131. Vascular Solutions Description and Business Overview

Table 132. Vascular Solutions Medical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 133. Vascular Solutions Product

Table 134. Vascular Solutions Recent Development

Table 135. Marine Polymer Technologies Corporation Information

Table 136. Marine Polymer Technologies Description and Business Overview

Table 137. Marine Polymer Technologies Medical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 138. Marine Polymer Technologies Product

Table 139. Marine Polymer Technologies Recent Development

Table 140. Z-Medica Corporation Information

Table 141. Z-Medica Description and Business Overview

Table 142. Z-Medica Medical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 143. Z-Medica Product

Table 144. Z-Medica Recent Development

Table 145. CryoLife Corporation Information

Table 146. CryoLife Description and Business Overview

Table 147. CryoLife Medical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 148. CryoLife Product

Table 149. CryoLife Recent Development

Table 150. BioCer Entwicklungs Corporation Information

Table 151. BioCer Entwicklungs Description and Business Overview

Table 152. BioCer Entwicklungs Medical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 153. BioCer Entwicklungs Product

Table 154. BioCer Entwicklungs Recent Development

Table 155. Biom?Up SAS Corporation Information

Table 156. Biom?Up SAS Description and Business Overview

Table 157. Biom?Up SAS Medical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 158. Biom?Up SAS Product

Table 159. Biom?Up SAS Recent Development

Table 160. Key Opportunities and Drivers: Impact Analysis (2021-2026)

Table 161. Key Challenges

Table 162. Market Risks

Table 163. Main Points Interviewed from Key Medical Hemostatic Agents Players

Table 164. Medical Hemostatic Agents Customers List

Table 165. Medical Hemostatic Agents Distributors List

Table 166. Research Programs/Design for This Report

Table 167. Key Data Information from Secondary Sources

Table 168. Key Data Information from Primary Sources

List of Figures

Figure 1. Medical Hemostatic Agents Product Picture

Figure 2. Global Medical Hemostatic Agents Sales Market Share by Type in 2020 & 2026

Figure 3. Gelation Sponge Product Picture

Figure 4. Oxidized Regenerated Cellulose Based Hemostats Product Picture

Figure 5. Others Product Picture

Figure 6. Global Medical Hemostatic Agents Sales Market Share by Application in 2020 & 2026

Figure 7. Hospitals

Figure 8. Surgical Centers

Figure 9. Clnics

Figure 10. Others

Figure 11. Medical Hemostatic Agents Report Years Considered

Figure 12. Global Medical Hemostatic Agents Market Size 2015-2026 (US$ Million)

Figure 13. Global Medical Hemostatic Agents Sales 2015-2026 (K Units)

Figure 14. Global Medical Hemostatic Agents Market Size Market Share by Region: 2020 Versus 2026

Figure 15. Global Medical Hemostatic Agents Sales Market Share by Region (2015-2020)

Figure 16. Global Medical Hemostatic Agents Sales Market Share by Region in 2019

Figure 17. Global Medical Hemostatic Agents Revenue Market Share by Region (2015-2020)

Figure 18. Global Medical Hemostatic Agents Revenue Market Share by Region in 2019

Figure 19. Global Medical Hemostatic Agents Sales Share by Manufacturer in 2019

Figure 20. The Top 10 and 5 Players Market Share by Medical Hemostatic Agents Revenue in 2019

Figure 21. Medical Hemostatic Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019

Figure 22. Global Medical Hemostatic Agents Sales Market Share by Type (2015-2020)

Figure 23. Global Medical Hemostatic Agents Sales Market Share by Type in 2019

Figure 24. Global Medical Hemostatic Agents Revenue Market Share by Type (2015-2020)

Figure 25. Global Medical Hemostatic Agents Revenue Market Share by Type in 2019

Figure 26. Global Medical Hemostatic Agents Market Share by Price Range (2015-2020)

Figure 27. Global Medical Hemostatic Agents Sales Market Share by Application (2015-2020)

Figure 28. Global Medical Hemostatic Agents Sales Market Share by Application in 2019

Figure 29. Global Medical Hemostatic Agents Revenue Market Share by Application (2015-2020)

Figure 30. Global Medical Hemostatic Agents Revenue Market Share by Application in 2019

Figure 31. United States Medical Hemostatic Agents Sales Growth Rate 2015-2026 (K Units)

Figure 32. United States Medical Hemostatic Agents Revenue Growth Rate 2015-2026 (US$ Million)

Figure 33. United States Medical Hemostatic Agents Market Share in Global Market 2015-2026

Figure 34. United States 5 and 10 Largest Medical Hemostatic Agents Players Market Share by Revenue in Medical Hemostatic Agents in 2019

Figure 35. United States Medical Hemostatic Agents Revenue Share by Type (2015-2020)

Figure 36. United States Medical Hemostatic Agents Revenue Growth Rate by Type in 2015 & 2019

Figure 37. United States Medical Hemostatic Agents Revenue Share by Application (2015-2020)

Figure 38. United States Medical Hemostatic Agents Revenue Growth Rate by Application in 2015 & 2019

Figure 39. North America Medical Hemostatic Agents Sales Growth Rate 2015-2020 (K Units)

Figure 40. North America Medical Hemostatic Agents Revenue Growth Rate 2015-2020 (US$ Million)

Figure 41. North America Medical Hemostatic Agents Sales Market Share by Country in 2019

Figure 42. North America Medical Hemostatic Agents Revenue Market Share by Country in 2019

Figure 43. U.S. Medical Hemostatic Agents Sales Growth Rate (2015-2020) (K Units)

Figure 44. U.S. Medical Hemostatic Agents Revenue Growth Rate (2015-2020) (US$ Million)

Figure 45. Canada Medical Hemostatic Agents Sales Growth Rate (2015-2020) (K Units)

Figure 46. Canada Medical Hemostatic Agents Revenue Growth Rate (2015-2020) (US$ Million)

Figure 47. Europe Medical Hemostatic Agents Sales Growth Rate 2015-2020 (K Units)

Figure 48. Europe Medical Hemostatic Agents Revenue Growth Rate 2015-2020 (US$ Million)

Figure 49. Europe Medical Hemostatic Agents Sales Market Share by Country in 2019

Figure 50. Europe Medical Hemostatic Agents Revenue Market Share by Country in 2019

Figure 51. Germany Medical Hemostatic Agents Sales Growth Rate (2015-2020) (K Units)

Figure 52. Germany Medical Hemostatic Agents Revenue Growth Rate (2015-2020) (US$ Million)

Figure 53. France Medical Hemostatic Agents Sales Growth Rate (2015-2020) (K Units)

Figure 54. France Medical Hemostatic Agents Revenue Growth Rate (2015-2020) (US$ Million)

Figure 55. U.K. Medical Hemostatic Agents Sales Growth Rate (2015-2020) (K Units)

Figure 56. U.K. Medical Hemostatic Agents Revenue Growth Rate (2015-2020) (US$ Million)

Figure 57. Italy Medical Hemostatic Agents Sales Growth Rate (2015-2020) (K Units)

Figure 58. Italy Medical Hemostatic Agents Revenue Growth Rate (2015-2020) (US$ Million)

Figure 59. Russia Medical Hemostatic Agents Sales Growth Rate (2015-2020) (K Units)

Figure 60. Russia Medical Hemostatic Agents Revenue Growth Rate (2015-2020) (US$ Million)

Figure 61. Asia Pacific Medical Hemostatic Agents Sales Growth Rate 2015-2020 (K Units)

Figure 62. Asia Pacific Medical Hemostatic Agents Revenue Growth Rate 2015-2020 (US$ Million)

Figure 63. Asia Pacific Medical Hemostatic Agents Sales Market Share by Region in 2019

Figure 64. Asia Pacific Medical Hemostatic Agents Revenue Market Share by Region in 2019

Figure 65. China Medical Hemostatic Agents Sales Growth Rate (2015-2020) (K Units)

Figure 66. China Medical Hemostatic Agents Revenue Growth Rate (2015-2020) (US$ Million)

Figure 67. Japan Medical Hemostatic Agents Sales Growth Rate (2015-2020) (K Units)

Figure 68. Japan Medical Hemostatic Agents Revenue Growth Rate (2015-2020) (US$ Million)

Figure 69. South Korea Medical Hemostatic Agents Sales Growth Rate (2015-2020) (K Units)

Figure 70. South Korea Medical Hemostatic Agents Revenue Growth Rate (2015-2020) (US$ Million)

Figure 71. India Medical Hemostatic Agents Sales Growth Rate (2015-2020) (K Units)

Figure 72. India Medical Hemostatic Agents Revenue Growth Rate (2015-2020) (US$ Million)

Figure 73. Australia Medical Hemostatic Agents Sales Growth Rate (2015-2020) (K Units)

Figure 74. Australia Medical Hemostatic Agents Revenue Growth Rate (2015-2020) (US$ Million)

Figure 75. Taiwan Medical Hemostatic Agents Sales Growth Rate (2015-2020) (K Units)

Figure 76. Taiwan Medical Hemostatic Agents Revenue Growth Rate (2015-2020) (US$ Million)

Figure 77. Indonesia Medical Hemostatic Agents Sales Growth Rate (2015-2020) (K Units)

Figure 78. Indonesia Medical Hemostatic Agents Revenue Growth Rate (2015-2020) (US$ Million)

Figure 79. Thailand Medical Hemostatic Agents Sales Growth Rate (2015-2020) (K Units)

Figure 80. Thailand Medical Hemostatic Agents Revenue Growth Rate (2015-2020) (US$ Million)

Figure 81. Malaysia Medical Hemostatic Agents Sales Growth Rate (2015-2020) (K Units)

Figure 82. Malaysia Medical Hemostatic Agents Revenue Growth Rate (2015-2020) (US$ Million)

Figure 83. Philippines Medical Hemostatic Agents Sales Growth Rate (2015-2020) (K Units)

Figure 84. Philippines Medical Hemostatic Agents Revenue Growth Rate (2015-2020) (US$ Million)

Figure 85. Vietnam Medical Hemostatic Agents Sales Growth Rate (2015-2020) (K Units)

Figure 86. Vietnam Medical Hemostatic Agents Revenue Growth Rate (2015-2020) (US$ Million)

Figure 87. Latin America Medical Hemostatic Agents Sales Growth Rate 2015-2020 (K Units)

Figure 88. Latin America Medical Hemostatic Agents Revenue Growth Rate 2015-2020 (US$ Million)

Figure 89. Latin America Medical Hemostatic Agents Sales Market Share by Country in 2019

Figure 90. Latin America Medical Hemostatic Agents Revenue Market Share by Country in 2019

Figure 91. Mexico Medical Hemostatic Agents Sales Growth Rate (2015-2020) (K Units)

Figure 92. Mexico Medical Hemostatic Agents Revenue Growth Rate (2015-2020) (US$ Million)

Figure 93. Brazil Medical Hemostatic Agents Sales Growth Rate (2015-2020) (K Units)

Figure 94. Brazil Medical Hemostatic Agents Revenue Growth Rate (2015-2020) (US$ Million)

Figure 95. Argentina Medical Hemostatic Agents Sales Growth Rate (2015-2020) (K Units)

Figure 96. Argentina Medical Hemostatic Agents Revenue Growth Rate (2015-2020) (US$ Million)

Figure 97. Middle East and Africa Medical Hemostatic Agents Sales Growth Rate 2015-2020 (K Units)

Figure 98. Middle East and Africa Medical Hemostatic Agents Revenue Growth Rate 2015-2020 (US$ Million)

Figure 99. Middle East and Africa Medical Hemostatic Agents Sales Market Share by Country in 2019

Figure 100. Middle East and Africa Medical Hemostatic Agents Revenue Market Share by Country in 2019

Figure 101. Turkey Medical Hemostatic Agents Sales Growth Rate (2015-2020) (K Units)

Figure 102. Turkey Medical Hemostatic Agents Revenue Growth Rate (2015-2020) (US$ Million)

Figure 103. Saudi Arabia Medical Hemostatic Agents Sales Growth Rate (2015-2020) (K Units)

Figure 104. Saudi Arabia Medical Hemostatic Agents Revenue Growth Rate (2015-2020) (US$ Million)

Figure 105. U.A.E Medical Hemostatic Agents Sales Growth Rate (2015-2020) (K Units)

Figure 106. U.A.E Medical Hemostatic Agents Revenue Growth Rate (2015-2020) (US$ Million)

Figure 107. Porter's Five Forces Analysis

Figure 108. Medical Hemostatic Agents Value Chain

Figure 109. Channels of Distribution

Figure 110. Distributors Profiles

Figure 111. Bottom-up and Top-down Approaches for This Report

Figure 112. Data Triangulation

Figure 113. Key Executives Interviewed

Ethicon

Pfizer

Baxter International

C. R. Bard

The Medicines Company

Anika Therapeutics

Advanced Medical Solutions

Integra LifeSciences

B Braun Melsungen

Gelita Medical

Equimedical

Vascular Solutions

Marine Polymer Technologies

Z-Medica

CryoLife

BioCer Entwicklungs

Biom?Up SAS

CHOOSE YOUR BUYING OPTION COVID-19 Revised Pricing Of the Month

SECURITY ASSUREDpayment image

Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

CHECK TODAYS BEST PRICE

BEST PRICE: $3159

SOME OF OUR CLIENTS

OUR KEY POINTS

  • Comprehensive Research

    Offers Penetrative insights & holistic understanding of the market

  • Data Accuracy & Reliability

    Strictly follows the Research Meth-odology for flawless results

  • Competitive Pricing

    Ensure the best and affordable pricing

  • Security & Confidentiality

    All your transactions are secured end-to-end, ensuring a satisfactory purchase